ZYME as reported
Zymeworks Inc. reported $81M of revenue over the trailing twelve months, −13% on the year before. 8 reported series are charted on this page, each one as filed.
$81M
Revenue, trailing twelve months · to Q1 2026 · −13% against the twelve months before
- Net Income
- −$103M
Net Income · −9.7% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- −$77M
Free Cash Flow · −0.74% year on year · trailing twelve months to Q1 2026
- Op Margin
- −948%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $81M | −13% | Q1 2026 |
| Net Income | −$103M | −9.7% | Q1 2026 |
| EPS | −$1.37 | −8.7% | Q1 2026 |
| Op Margin | −948% | n/a | Q1 2026 |
| Net Margin | −885% | n/a | Q1 2026 |
| ROE | −34% | n/a | Q1 2026 |
| ROA | −20% | n/a | Q1 2026 |
| Free Cash Flow | −$77M | −0.74% | Q1 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Zymeworks Inc. (ZYME) - Revenue & ProfitRevenue & ProfitZymeworks Inc. (ZYME)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com